Journal of Animal Science, Vol 73, Issue 2 508-515, Copyright © 1995 by American Society of Animal Science

JOURNAL ARTICLE

Acute hepatic and renal toxicity in lambs dosed with fumonisin-containing culture material

T. S. Edrington, C. A. Kamps-Holtzapple, R. B. Harvey, L. F. Kubena, M. H. Elissalde and G. E. Rottinghaus
Food Animal Protection Research Laboratory, USDA, College Station, TX 77845, USA.

To examine the effects of acute exposure to fumonisin-containing culture material (FCCM), 15 crossbred wether lambs were dosed intraruminally with FCCM containing 0 (CONTROL, n = 3), 11.1 (LOW, n = 4), 22.2 (MED, n = 4), or 45.5 (HIGH, n = 4) mg of total fumonisins (B1, B2, and B3)/kg BW daily for 4 d. Blood samples were collected daily, and on d 11 lambs were killed and necropsied. Changes in serum constituents in fumonisin-treated lambs indicative of liver damage, included increased (P < .05) activities of alkaline phosphatase, gamma-glutamyl transferase, aspartate aminotransferase, and lactate dehydrogenase. Serum concentrations of cholesterol, triglycerides, urea nitrogen, and creatinine were also increased (P < .05) in lambs dosed with FCCM. Hemoglobin tended to increase (P = .07) and white blood cell count tended to decrease (P = .08) in HIGH lambs and activated partial thromboplastin time tended to decrease (P < .10) in lambs dosed with LOW and MED treatments. Mitogen-induced lymphocyte blastogenesis was not different (P = .14) among treatments. Feed intake markedly decreased (P < .01) following the first dosing of FCCM and continued to decline throughout the study. Ruminal VFA concentrations and pH tended to decrease (P < .10) at d 11 in treated lambs. Relative liver and kidney weights (g/100 g of BW) increased (P < .05) in fumonisin-treated lambs. Histiolgical examination revealved tubular nephrosis and mild hepatopathy in dosed lambs. Lambs receiving the HIGH treatment died on d 3, 4, 5, and 7 of the study and on d 9 one lamb on the MED treatment died.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				R. W Coppock and B. J Jacobsen Mycotoxins in animal and human patients Toxicology and Industrial Health, October 1, 2009; 25(9-10): 637 - 655. [Abstract] [PDF]

				F. A. Morsy, M. A. Badawy, and A. R. H. Farrag The Protective Effect of Melatonin against Fumonisin-Induced Renal Damage in Rats International Journal of Toxicology, November 1, 2006; 25(6): 523 - 529. [Abstract] [Full Text] [PDF]

				I. P. Oswald, C. Desautels, J. Laffitte, S. Fournout, S. Y. Peres, M. Odin, P. Le Bars, J. Le Bars, and J. M. Fairbrother Mycotoxin Fumonisin B1 Increases Intestinal Colonization by Pathogenic Escherichia coli in Pigs Appl. Envir. Microbiol., October 1, 2003; 69(10): 5870 - 5874. [Abstract] [Full Text] [PDF]

				S. Mathur, P. D. Constable, R. M. Eppley, M. E. Tumbleson, G. W. Smith, W. J. Tranquilli, D. E. Morin, and W. M. Haschek Fumonisin B1 Increases Serum Sphinganine Concentration but Does Not Alter Serum Sphingosine Concentration or Induce Cardiovascular Changes in Milk-Fed Calves Toxicol. Sci., April 1, 2001; 60(2): 379 - 384. [Abstract] [Full Text] [PDF]

				S. Mathur, P. D. Constable, R. M. Eppley, A. L. Waggoner, M. E. Tumbleson, and W. M. Haschek Fumonisin B1 Is Hepatotoxic and Nephrotoxic in Milk-Fed Calves Toxicol. Sci., April 1, 2001; 60(2): 385 - 396. [Abstract] [Full Text] [PDF]